116 related articles for article (PubMed ID: 2579784)
1. [Long-term therapy of cancer pain. A controlled study on buprenorphine].
Zenz M; Piepenbrock S; Tryba M; Glocke M; Everlien M; Klauke W
Dtsch Med Wochenschr; 1985 Mar; 110(12):448-53. PubMed ID: 2579784
[TBL] [Abstract][Full Text] [Related]
2. [Sublingual buprenorphine tablets: initial clinical experiences in long-term therapy of cancer pain].
Zenz M; Piepenbrock S; Tryba M; Klauke W; Everlien M
Fortschr Med; 1983 Feb; 101(5):191-4. PubMed ID: 6403440
[TBL] [Abstract][Full Text] [Related]
3. [Sublingual buprenorphine in the treatment of pain caused by cancer. Transition to buprenorphine from other opiates].
Enig B
Ugeskr Laeger; 1983 Oct; 145(42):3236-40. PubMed ID: 6197797
[No Abstract] [Full Text] [Related]
4. Long-term management of chronic pain with transdermal buprenorphine: a multicenter, open-label, follow-up study in patients from three short-term clinical trials.
Likar R; Kayser H; Sittl R
Clin Ther; 2006 Jun; 28(6):943-52. PubMed ID: 16860176
[TBL] [Abstract][Full Text] [Related]
5. [Controlled study of the analgesic effect and tolerability of buprenorphine in cancer patients].
Dini D; Fassio T; Gottlieb A; Gini M
Minerva Med; 1986 Jan; 77(3-4):93-104. PubMed ID: 3511410
[TBL] [Abstract][Full Text] [Related]
6. Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study.
Mercadante S; Porzio G; Ferrera P; Aielli F; Verna L; Tirelli W; Villari P; Casuccio A
Clin Ther; 2009 Oct; 31(10):2134-8. PubMed ID: 19922884
[TBL] [Abstract][Full Text] [Related]
7. Intra-muscular buprenorphine--clinical experience in its use for relieving pain due to malignant disease.
Ostrowski MJ; Jackson AW
Br J Clin Pract; 1979 Oct; 33(10):286, 293. PubMed ID: 526414
[No Abstract] [Full Text] [Related]
8. [Effect of a long-acting analgesic, buprenorphine on cancer pain--a single-blind crossover comparison with pentazocine].
Taguchi T
Gan To Kagaku Ryoho; 1982 Feb; 9(2):250-7. PubMed ID: 7184401
[TBL] [Abstract][Full Text] [Related]
9. A long-term open, clinical and pharmacokinetic assessment of sublingual buprenorphine in patients suffering from chronic pain.
Adriaensen H; Mattelaer B; Vanmeenen H
Acta Anaesthesiol Belg; 1985 Mar; 36(1):33-40. PubMed ID: 4013631
[TBL] [Abstract][Full Text] [Related]
10. [Temgesic--analgesic with a central action].
Fortschr Med; 1982 Aug; 100(30):1414-5. PubMed ID: 6182077
[No Abstract] [Full Text] [Related]
11. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
12. [Home palliative care--2 case reports: a long-term cancer pain management with transdermal fentanyl].
Fujimoto M; Sakuyama T; Mizutani Y; Kuroda T; Yanaga K
Gan To Kagaku Ryoho; 2004 Dec; 31 Suppl 2():190-3. PubMed ID: 15645768
[TBL] [Abstract][Full Text] [Related]
13. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Sorge J; Sittl R
Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
[TBL] [Abstract][Full Text] [Related]
14. Oral tramadol and buprenorphine in tumour pain. An Italian multicentre trial.
Brema F; Pastorino G; Martini MC; Gottlieb A; Luzzani M; Libretti A; Saccà L; Cigolari S
Int J Clin Pharmacol Res; 1996; 16(4-5):109-16. PubMed ID: 9172009
[TBL] [Abstract][Full Text] [Related]
15. Changes in the prescribed daily doses of transdermal fentanyl and transdermal buprenorphine during treatment of patients with cancer and noncancer pain in Germany: results of a retrospective cohort study.
Sittl R; Nuijten M; Nautrup BP
Clin Ther; 2005 Jul; 27(7):1022-31. PubMed ID: 16154481
[TBL] [Abstract][Full Text] [Related]
16. Effects of transdermal buprenorphine on patients-reported outcomes in cancer patients: results from the Cancer Pain Outcome Research (CPOR) Study Group.
Apolone G; Corli O; Negri E; Mangano S; Montanari M; Greco MT; ; Apolone G; Bertetto O; Caraceni A; Corli O; De Conno F; Labianca R; Maltoni M; Nicora Maria F; Torri V; Zucco F
Clin J Pain; 2009 Oct; 25(8):671-82. PubMed ID: 19920716
[TBL] [Abstract][Full Text] [Related]
17. [Clinical trial of butorphanol tartrate in cancer patients: evaluation for analgesic effects and safety on the basis of long term administration].
Konno K; Nakai Y; Ebina A; Sato M; Nagai K; Hayashi I; Ito T
Gan To Kagaku Ryoho; 1983 Jul; 10(7):1634-45. PubMed ID: 6347086
[TBL] [Abstract][Full Text] [Related]
18. Gastrointestinal symptoms under opioid therapy: a prospective comparison of oral sustained-release hydromorphone, transdermal fentanyl, and transdermal buprenorphine.
Wirz S; Wittmann M; Schenk M; Schroeck A; Schaefer N; Mueller M; Standop J; Kloecker N; Nadstawek J
Eur J Pain; 2009 Aug; 13(7):737-43. PubMed ID: 18977159
[TBL] [Abstract][Full Text] [Related]
19. Chronic analgesic study on buprenorphine action in cancer pain. Comparison with pentazocine.
Ventafridda V; De Conno F; Guarise G; Tamburini M; Savio G
Arzneimittelforschung; 1983; 33(4):587-90. PubMed ID: 6683540
[TBL] [Abstract][Full Text] [Related]
20. [Retard morphine in the long-term therapy of severe tumor pain].
Zenz M; Strumpf M; Tryba M; Röhrs E; Steffmann B
Dtsch Med Wochenschr; 1989 Jan; 114(2):43-7. PubMed ID: 2910700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
